Paxman AB (publ) (PXMBF) Financials

PXMBF Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 49.5 million 6.9 million
Dec. 31, 2025 51.9 million 8.0 million
Sept. 30, 2025 51.8 million 6.4 million
June 30, 2025 52.8 million 7.7 million

PXMBF Free Cash Flow and Stock based compensation

No data available :(

PXMBF Net Income

No data available :(

PXMBF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 11.0 million 365113 -
Dec. 31, 2025 13.1 million 281238 -
Sept. 30, 2025 13.8 million 357579 -
June 30, 2025 15.8 million 374675 -

PXMBF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 2.4 million
Dec. 31, 2025 2.5 million
Sept. 30, 2025 2.4 million
June 30, 2025 2.4 million

PXMBF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 418730 - - -
Dec. 31, 2025 555651 - - -
Sept. 30, 2025 456848 - - -
June 30, 2025 501507 - - -

PXMBF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 9.3 million 9.3 million
Dec. 31, 2025 9.1 million 9.5 million
Sept. 30, 2025 9.2 million 3.2 million
June 30, 2025 7.9 million 2.5 million

PXMBF

Price: $3.50

52 week price:
2.80
3.50

Earnings Per Share: 0.12 USD

P/E Ratio: 23.33

Exchange: PNK

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 119.9 million

Links: